# Program 1 Synthetic Read-Only UI Evaluation Track Phase B Closure Report

Status: closed.

## Implemented Improvements

- standard tablist, tab, and tabpanel semantics
- selected-tab and panel relationships
- Arrow Left, Arrow Right, Home, and End keyboard navigation
- roving tab index and focus transfer
- visible focus treatment
- selected scenario announcement with `aria-pressed`
- semantic synthetic evidence, findings, timeline, and completeness lists
- status semantics for state pills
- explicit timeline, evidence, and findings empty states
- descriptive comparison table caption
- reduced-motion override
- responsive shrink and narrow-width safeguards retained from Phase A
- smoke regression guards for the Phase B contracts

## Browser Results

- all five repository-controlled scenarios rendered and changed correctly
- safety boundary remained visible for all scenarios
- tab keyboard navigation and focus behavior passed
- filtered findings empty state passed
- 640 px 200%-equivalent reflow proxy passed without page overflow
- 390 px mobile reflow passed without page overflow
- comparison table stayed inside its container and scrolled internally
- representative contrast ratios ranged from 4.68:1 to 6.16:1
- no Program 1 console errors were observed

## Validation

- frontend typecheck: pass
- frontend smoke: pass
- frontend production build: pass
- Program 1 sandbox tests: 53 pass
- diff whitespace check: pass

## Limitations

- no external clinician participated
- no formal WCAG audit or certification was performed
- no assistive-technology certification is claimed
- browser screenshot capture is not required evidence; rendered DOM, computed styles, interaction state, and console output were used
- no clinical, production, or go-live claim is made

## Closure Decision

Program 1 Synthetic Read-Only UI Evaluation Track Phase B is complete and closed inside the local, synthetic-only, read-only boundary.

No backend Program 1 integration, real data, PHI/PII, persistence, export, clinical workflow, diagnosis, treatment, triage, production deployment, clinical use, or go-live is authorized.

No Phase C or external clinician session is started.

Default posture: `STOP AND HOLD`.

